Roldan de Guia

Dr. Roldan de Guia

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 June 2019 in Physiological Reports
Verified
Journal Article
Open access
PDF file
RGRoldan de Guia
Roldan de Guia
MAMarianne Agerholm
Marianne Agerholm
TNThomas S. Nielsen
Thomas S. Nielsen
LCLeslie A. Consitt
Leslie A. Consitt
DSDitte Søgaard
Ditte Søgaard
JTJonas Thue Treebak
Jonas Thue Treebak
Aging decreases skeletal muscle mass and strength, but aerobic and resistance exercise training maintains skeletal muscle function. NAD+ is a coenzyme for ATP production and a required substrate for enzymes regulating cellular homeostasis. In skeletal muscle, NAD+ is mainly generated by the NAD+ salvage pathway in which nicotinamide phosphoribosyltransferase (NAMPT) is rate‐limiting. NAMPT decreases with age in human skeletal muscle, and aerobic exercise training increases NAMPT levels in young men. However, whether distinct modes of exercise training increase NAMPT levels in both young and old people is unknown. We assessed the effects of 12 weeks of aerobic and resistance exercise training on skeletal muscle abundance of NAMPT, nicotinamide riboside kinase 2 (NRK2), and nicotinamide mononucleotide adenylyltransferase (NMNAT) 1 and 3 in young (≤35 years) and older (≥55 years) individuals. NAMPT in skeletal muscle correlated negatively with age (r2 = 0.297, P < 0.001, n = 57), and VO2peak was the best predictor of NAMPT levels. Moreover, aerobic exercise training increased NAMPT abundance 12% and 28% in young and older individuals, respectively, whereas resistance exercise training increased NAMPT abundance 25% and 30% in young and in older individuals, respectively. None of the other proteins changed with exercise training. In a separate cohort of young and old people, levels of NAMPT, NRK1, and NMNAT1/2 in abdominal subcutaneous adipose tissue were not affected by either age or 6 weeks of high‐intensity interval training. Collectively, exercise training reverses the age‐dependent decline in skeletal muscle NAMPT abundance, and our findings highlight the value of exercise training in ameliorating age‐associated deterioration of skeletal muscle function.

1 August 2014 in Hormone Molecular Biology and Clinical Investigation
Verified
Journal Article
Closed access
RGRoldan de Guia
Roldan de Guia
Adam J. RoseAdam J. Rose
Adam J. Rose
SHStephan Herzig
Stephan Herzig
Glucocorticoids (GC) and their cognate intracellular receptor, the glucocorticoid receptor (GR), have been characterised as critical checkpoints in the endocrine control of energy homeostasis in mammals. Indeed, aberrant GC action has been linked to a variety of severe metabolic diseases, including obesity, insulin resistance and type 2 diabetes. As a steroid-binding member of the nuclear receptor superfamily of transcription factors, the GR translocates into the cell nucleus upon GC binding where it serves as a transcriptional regulator of distinct GC-responsive target genes that are – in many cases – associated with glucose and lipid regulatory pathways and thereby intricately control both physiological and pathophysiological systemic energy homeostasis. Here, we summarize the current knowledge of GC/GR function in energy metabolism and systemic metabolic dysfunction, particularly focusing on glucose and lipid metabolism.

1 October 2015 in Molecular Metabolism
Verified
Journal Article
Open access
JOJürgen G. Okun
Jürgen G. Okun
SCSean Conway
Sean Conway
KSKathrin V. Schmidt
Kathrin V. Schmidt
JSJonas Schumacher
Jonas Schumacher
XWXiaoyue Wang
Xiaoyue Wang
Adam J. RoseAdam J. Rose
Adam J. Rose
One of the major side effects of glucocorticoid (GC) treatment is lean tissue wasting, indicating a prominent role in systemic amino acid metabolism. In order to uncover a novel aspect of GCs and their intracellular-receptor, the glucocorticoid receptor (GR), on metabolic control, we conducted amino acid and acylcarnitine profiling in human and mouse models of GC/GR gain- and loss-of-function. Blood serum and tissue metabolite levels were determined in Human Addison's disease (AD) patients as well as in mouse models of systemic and liver-specific GR loss-of-function (AAV-miR-GR) with or without dexamethasone (DEX) treatments. Body composition and neuromuscular and metabolic function tests were conducted in vivo and ex vivo, the latter using precision cut liver slices. A serum metabolite signature of impaired urea cycle function (i.e. higher [ARG]:[ORN + CIT]) was observed in human (CTRL: 0.45 ± 0.03, AD: 1.29 ± 0.04; p < 0.001) and mouse (AAV-miR-NC: 0.97 ± 0.13, AAV-miR-GR: 2.20 ± 0.19; p < 0.001) GC/GR loss-of-function, with similar patterns also observed in liver. Serum urea levels were consistently affected by GC/GR gain- (∼+32%) and loss (∼-30%) -of-function. Combined liver-specific GR loss-of-function with DEX treatment revealed a tissue-autonomous role for the GR to coordinate an upregulation of liver urea production rate in vivo and ex vivo, and prevent hyperammonaemia and associated neuromuscular dysfunction in vivo. Liver mRNA expression profiling and GR-cistrome mining identified Arginase I (ARG1) a urea cycle gene targeted by the liver GR. The liver GR controls systemic and liver urea cycle function by transcriptional regulation of ARG1 expression.

1 January 2015
Verified
Book Chapter
Closed access
PDF file
RGRoldan de Guia
Roldan de Guia
SHStephan Herzig
Stephan Herzig

15 December 2014 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
RGRoldan de Guia
Roldan de Guia
Adam J. RoseAdam J. Rose
Adam J. Rose
ASAnke Sommerfeld
Anke Sommerfeld
OSOksana Seibert
Oksana Seibert
DSDaniela Strzoda
Daniela Strzoda
SHStephan Herzig
Stephan Herzig
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

3 May 2016 in EMBO Molecular Medicine
Verified
Journal Article
Open access
PDF file
JFJessica Fuhrmeister
Jessica Fuhrmeister
AZAnnika Zota
Annika Zota
TSTjeerd P Sijmonsma
Tjeerd P Sijmonsma
OSOksana Seibert
Oksana Seibert
ŞCŞahika Cıngır
Şahika Cıngır
Adam J. RoseAdam J. Rose
Adam J. Rose
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.